Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ALPHA & OMEGA SEMICONDUCTOR Ltd Director's Dealing 2016

Apr 4, 2016

32375_dirs_2016-04-04_b0cbee75-faba-49b4-9f5c-12bd76ad788b.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ALPHA & OMEGA SEMICONDUCTOR Ltd (AOSL)
CIK: 0001387467
Period of Report: 2016-03-31

Reporting Person: Chang Daniel Kuang Ming (Senior VP of Marketing)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2016-03-31 Common Share M 21000 $7.60 Acquired 65060 Direct
2016-03-31 Common Share S 21000 $11 Disposed 44060 Direct
2016-03-31 Common Share M 7875 $8.45 Acquired 51935 Direct
2016-03-31 Common Share S 7875 $11.50 Disposed 44060 Direct
2016-03-31 Common Share M 16770 $7.44 Acquired 60830 Direct
2016-03-31 Common Share S 16770 $11 Disposed 44060 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2016-03-31 Employee Share Option (right to buy) $7.6 M 21000 Disposed 2019-05-04 Common Shares (21000.0) Direct
2016-03-31 Employee Share Option (right to buy) $8.45 M 7875 Disposed 2023-02-13 Common Shares (7875.0) Direct
2016-03-31 Employee Share Option (right to buy) $7.44 M 16770 Disposed 2024-03-16 Common Shares (16770.0) Direct

Footnotes

F1: Includes an aggregate of 38,666 shares subject to restricted share unit awards granted on April 26, 2012, February 14, 2013, March 17, 2014, March 16, 2015, and March 15, 2016, which will be issued as such units vest in accordance with their terms.

F2: The sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 24, 2016.

F3: The price reported in Column 4 is the exact price at which all shares were sold.

F4: The option is fully vested and immediately exercisable for all option shares.

F5: The option was granted on February 14, 2013 and became exercisable with respect to one-fourth (1/4) of the underlying shares on the first anniversary of the grant date, and thereafter the balance of the option shares became exercisable in a series of thirty-six (36) successive equal monthly installments.

F6: The option was granted on March 17, 2014 and became exercisable with respect to one-fourth (1/4) of the underlying shares on March 15, 2015, and thereafter the balance of the option shares became exercisable in a series of thirty-six (36) successive equal monthly installments.